Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level

Publikation: Bidrag til tidsskriftReviewForskning

Standard

Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level. / Van Hall, Gerrit.

I: Proceedings of the Nutrition Society, Bind 58, Nr. 4, 1999, s. 979-86.

Publikation: Bidrag til tidsskriftReviewForskning

Harvard

Van Hall, G 1999, 'Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level', Proceedings of the Nutrition Society, bind 58, nr. 4, s. 979-86.

APA

Van Hall, G. (1999). Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level. Proceedings of the Nutrition Society, 58(4), 979-86.

Vancouver

Van Hall G. Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level. Proceedings of the Nutrition Society. 1999;58(4):979-86.

Author

Van Hall, Gerrit. / Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level. I: Proceedings of the Nutrition Society. 1999 ; Bind 58, Nr. 4. s. 979-86.

Bibtex

@article{e86fd4d04f7311de87b8000ea68e967b,
title = "Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level",
abstract = "The oxidation of fatty acids, carbohydrates and amino acids can be measured by quantifying the rate of excretion of labelled CO2 following administration of 14C- or 13C-labelled substrates at whole-body and tissue level. However, there is a theoretical need to correct the oxidation rates for the proportion of labelled CO2 that is produced via oxidation but not excreted. Furthermore, depending on the substrate and position of the C label(s), there may also be a need to correct for labelled C from the metabolized substrate that does not appear as CO2, but rather becomes temporarily fixed in other metabolites. The bicarbonate correction factor is used to correct for the labelled CO2 not excreted. Recently, an acetate correction factor has been proposed for the simultaneous correction of CO2 not excreted and label fixed in other metabolites via isotopic exchange reactions, mainly in the tricarboxylic acid cycle. Changes in metabolic rate induced, for example, by feeding, hormonal changes and physical activity, as well as infusion time, have been shown to affect both correction factors. The present paper explains the theoretical and physiological basis of these correction factors and makes recommendations as to how these correction factors should be used in various physiological conditions.",
author = "{Van Hall}, Gerrit",
note = "Keywords: Acetates; Bicarbonates; Carbon Dioxide; Carbon Isotopes; Humans; Isotope Labeling; Muscle, Skeletal; Oxidation-Reduction",
year = "1999",
language = "English",
volume = "58",
pages = "979--86",
journal = "Proceedings of the Nutrition Society",
issn = "0029-6651",
publisher = "Cambridge University Press",
number = "4",

}

RIS

TY - JOUR

T1 - Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level

AU - Van Hall, Gerrit

N1 - Keywords: Acetates; Bicarbonates; Carbon Dioxide; Carbon Isotopes; Humans; Isotope Labeling; Muscle, Skeletal; Oxidation-Reduction

PY - 1999

Y1 - 1999

N2 - The oxidation of fatty acids, carbohydrates and amino acids can be measured by quantifying the rate of excretion of labelled CO2 following administration of 14C- or 13C-labelled substrates at whole-body and tissue level. However, there is a theoretical need to correct the oxidation rates for the proportion of labelled CO2 that is produced via oxidation but not excreted. Furthermore, depending on the substrate and position of the C label(s), there may also be a need to correct for labelled C from the metabolized substrate that does not appear as CO2, but rather becomes temporarily fixed in other metabolites. The bicarbonate correction factor is used to correct for the labelled CO2 not excreted. Recently, an acetate correction factor has been proposed for the simultaneous correction of CO2 not excreted and label fixed in other metabolites via isotopic exchange reactions, mainly in the tricarboxylic acid cycle. Changes in metabolic rate induced, for example, by feeding, hormonal changes and physical activity, as well as infusion time, have been shown to affect both correction factors. The present paper explains the theoretical and physiological basis of these correction factors and makes recommendations as to how these correction factors should be used in various physiological conditions.

AB - The oxidation of fatty acids, carbohydrates and amino acids can be measured by quantifying the rate of excretion of labelled CO2 following administration of 14C- or 13C-labelled substrates at whole-body and tissue level. However, there is a theoretical need to correct the oxidation rates for the proportion of labelled CO2 that is produced via oxidation but not excreted. Furthermore, depending on the substrate and position of the C label(s), there may also be a need to correct for labelled C from the metabolized substrate that does not appear as CO2, but rather becomes temporarily fixed in other metabolites. The bicarbonate correction factor is used to correct for the labelled CO2 not excreted. Recently, an acetate correction factor has been proposed for the simultaneous correction of CO2 not excreted and label fixed in other metabolites via isotopic exchange reactions, mainly in the tricarboxylic acid cycle. Changes in metabolic rate induced, for example, by feeding, hormonal changes and physical activity, as well as infusion time, have been shown to affect both correction factors. The present paper explains the theoretical and physiological basis of these correction factors and makes recommendations as to how these correction factors should be used in various physiological conditions.

M3 - Review

C2 - 10817166

VL - 58

SP - 979

EP - 986

JO - Proceedings of the Nutrition Society

JF - Proceedings of the Nutrition Society

SN - 0029-6651

IS - 4

ER -

ID: 12484830